"10.1371_journal.pone.0130277","plos one","2015-06-18T00:00:00Z","Markus Hecht; Sonja Erber; Thomas Harrer; Hartwig Klinker; Thomas Roth; Hans Parsch; Nora Fiebig; Rainer Fietkau; Luitpold V Distel","Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany; Department of Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany; Department of Internal Medicine 2, University Hospital Würzburg, Würzburg, Germany; Central Laboratory, University Hospital Erlangen, Erlangen, Germany","Conceived and designed the experiments: MH LVD TR. Performed the experiments: MH SE TR NF HK. Analyzed the data: MH LVD TH RF HP NF. Contributed reagents/materials/analysis tools: TH RF TR HP HK. Wrote the paper: MH SE TH TR HP RF LVD.","Markus Hecht reported payment for lectures from Merck and travel expenses from TEVA and Merck. Thomas Harrer reported past consultancy of BMS and GSK, payment for lectures from Gilead, Abbvie and Jannson, and travel expenses from Gilead, Janssen and BMS. Hartwig Klinker received grants, board membership fees and lecture fees from AbbVie, Boehringer, Bristol-Myers Squibb, Gilead, Glaxo-SmithKline, Hexal, Janssen-Cilag, MSD, Roche, and ViiV Healthcare. The other authors declare no conflict of interest. This did not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","06","Markus Hecht","MH",9,TRUE,3,5,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
